ClinicalTrials.gg
Drug

HES 130-0.4 clinical trials

studies test it
16
open now
0
in phase 3
1
first study started
2005

How each study uses HES 130-0.4 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Voluven
11
Voluven (Hydroxyethyl starch 130/0,4)
3
Venofundin
3
Hydroxyethyl starch
3

Studies by the year they started

16 studies that test it; most in 2012 (4)

Studies that test HES 130-0.4, by start year
YearStudies
20051
20061
20073
20092
20101
20111
20124
20171
20181
20221

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
7
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 3 · Other 13

Regional Hospital Holstebro (3) · Fresenius Kabi (2) · Mansoura University (1) · University Medical Centre Ljubljana (1) · Medical University of Vienna (1) · University Hospital, Linkoeping (1) · Yonsei University (1) · Seoul National University Bundang Hospital (1)

Often tested with

Tested in the same studies.

Sterofundin (1) · Hydroxyethyl Starch Derivatives (1) · Maleimide-polyethylene glycol-modified hemoglobin, MP4 (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses HES 130-0.4 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

As the comparator · 5 — what is tested is compared with HES 130-0.4